Fit by company stage
Veeva is the right answer for pharma companies that need a system of record across clinical, regulatory, and quality at scale. If you are preparing one IND with a team of eight, Veeva is the wrong size — the budget alone is off by an order of magnitude. Regfo is stage-appropriate: you onboard in an afternoon, get cited gap findings in seconds, and pay under $1,000/mo while you grow.
Regfo
Designed for Series A–C biotech — priced and sized for that stage.
Veeva Systems
Designed for commercial pharma — priced for that scale.